Comparison of docetaxel/cisplatin dosages of 75/60 and 60/60 mg/m2 for the treatment of non-small cell lung cancer

By                        

Experimental and Therapeutic Medicine, Vol. 4, Iss. 2, 2012-01 ,pp. : 317-322

Spandidos Publications

Access to resources Recommend Favorite

Vinorelbine, Ifosfamide and Cisplatin in Advanced Non-Small Cell Lung Cancer

By Tan Eng-Huat   Ang Peng Tiam   Wee Joseph   Fong Kam Weng   Leong Swan Swan   Khoo Kei Siong  

Acta Oncologica, Vol. 38, Iss. 5, 1999-06 ,pp. : 619-622

Informa Healthcare

Access to resources Recommend Favorite

Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment

By Maas K.W.   van der Lee I.   Bolt K.   Zanen P.   Lammers J.W.J.   Schramel F.M.N.H.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 345-351

Elsevier

Access to resources Recommend Favorite

Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer

By                      

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2577-2582

Spandidos Publications

Access to resources Recommend Favorite

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

By Mori K.   Hirose T.   Machida S.   Yokoyama K.   Tominaga K.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 503-505

Elsevier

Access to resources Recommend Favorite